Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,631,464
in 9 filings, $6.6M under 10b5-1 plans

Net −$6,631,464. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-04 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −10,292 $68.57 $706K 383,868
2026-05-14 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −679 $73.06 $50K 405,891
2026-05-14 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −7,221 $73.08 $528K 398,670
2026-05-14 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,100 $73.08 $153K 396,570
2026-05-14 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,572 $72.46 $186K 393,998
2026-05-13 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +12,500 406,570
2026-04-21 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,850 $70.91 $202K 394,070
2026-03-12 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,662 $64.08 $171K 396,920
2026-03-11 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +12,500 399,582
2026-02-18 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −7,371 $69.36 $511K 387,082
2026-01-08 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,514 $76.45 $192K 394,453
2026-01-07 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −3,016 $77.48 $234K 396,967
2026-01-06 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −5,149 $76.95 $396K 399,983
2026-01-02 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award +63,000 405,132
2026-01-02 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award · Stock Option (Right to Buy) +157,500 157,500
2025-12-30 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −8,089 $76.64 $620K 341,875
2025-12-02 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −3,428 $79.07 $271K 349,964
2025-12-01 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +15,625 353,392
2025-08-05 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −10,739 $51.74 $556K 337,767
2025-08-01 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award 10b5-1 +75,000 348,506

Page 1 of 2 · 39 trades